Development of a new risk scoring system based on spleen involvement and the lymphocyte/monocyte ratio for follicular lymphoma patients

Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype Differentiation

(2022) Johanna S. Enke et al.   Cancers

Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models

(2022) Yanan Li et al.   Cancer Management and Research

Radiologically‐guided percutaneous core needle biopsy of the spleen: a reliable and safe diagnostic procedure for neoplastic and reactive conditions

(2021) Valentina Fabiola Ilenia Sangiorgio et al.   HISTOPATHOLOGY

Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation

(2020) George Yang et al.   Blood Cancer Journal

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

(2020) Clara Sortais et al.   ANNALS OF HEMATOLOGY

Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma

(2020) Asmaa Mohsen et al.   Clinical Lymphoma Myeloma & Leukemia

Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma

(2020) Pauli Vähämurto et al.   Cancers

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)

(2020) Alden Alberto Moccia et al.   BRITISH JOURNAL OF HAEMATOLOGY

A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma

(2020) Pablo Mozas et al.   LEUKEMIA & LYMPHOMA

Missing Data in Clinical Research: A Tutorial on Multiple Imputation

(2020) Peter C. Austin et al.   CANADIAN JOURNAL OF CARDIOLOGY

Establishment of Best Practices for Evidence for Prediction

(2019) Russell A. Poldrack et al.   JAMA Psychiatry

Follicular lymphoma

(2019) Antonino Carbone et al.   Nature Reviews Disease Primers

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

(2018) Emmanuel Bachy et al.   BLOOD

Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study

(2017) Shing Fung Lee et al.   BMJ Open

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

(2016) Matthew J. Maurer et al.   AMERICAN JOURNAL OF HEMATOLOGY

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

(2016) V. Jurinovic et al.   BLOOD

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

(2016) S. H. Swerdlow et al.   BLOOD

Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model

(2016) Yiming Chen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Regression coefficient–based scoring system should be used to assign weights to the risk index

(2016) Hemalkumar B. Mehta et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models

(2016) Nils Ternès et al.   STATISTICS IN MEDICINE

Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

(2015) Luigi Marcheselli et al.   BRITISH JOURNAL OF HAEMATOLOGY

Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

(2015) Angelo Belotti et al.   Clinical Lymphoma Myeloma & Leukemia

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

(2015) Carla Casulo et al.   JOURNAL OF CLINICAL ONCOLOGY

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

(2015) Alessandro Pastore et al.   LANCET ONCOLOGY

Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma

(2014) Shogo Kumagai et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of Markers and Risk Prediction Models

(2013) Ben Van Calster et al.   MEDICAL DECISION MAKING

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma Project

(2012) Zdravko Mitrovic et al.   AMERICAN JOURNAL OF HEMATOLOGY

Spleen in haematological malignancies: spectrum of imaging findings

(2011) S S Saboo et al.   BRITISH JOURNAL OF RADIOLOGY

Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells

(2011) Francisca I Camacho et al.   MODERN PATHOLOGY

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

(2009) Massimo Federico et al.   JOURNAL OF CLINICAL ONCOLOGY